A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia
- 15 August 1999
- journal article
- Published by American Society of Hematology in Blood
- Vol. 94 (4), 1192-1200
- https://doi.org/10.1182/blood.v94.4.1192
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- All-trans-Retinoic Acid in Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1997
- Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemiaThe Lancet, 1994
- The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RARCell, 1991
- Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PMLCell, 1991
- Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)New England Journal of Medicine, 1991
- Treatment of Acute Promyelocytic Leukemia: A Report of 70 CasesLeukemia & Lymphoma, 1991
- Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acidThe Lancet, 1990
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958